Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifekaline vs amiodarone for new-onset atrial fibrillation or flutter after cardiac surgery
ChiCTR2000033860Phase 4Recruiting
- Sponsor
- Department of Cardiovascular Surgery, Shandong Provincial Hospital affiliated to Shandong First Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) and atrial flutter (AFL) comparing Nifekaline arm with Amiodarone arm (2 arms). Primary endpoint: Cardioversion of atrial fibrillation/atrial flutter. Started Jun 2020; status: recruiting.
02
Drugs
nifekalantamiodarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on ChiCTR2000033860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033860.